Regarding antidiabetic medications, epidemiological studies suggest that whereas metformin could act as antineoplastic agent, therapies increasing circulating levels of insulin (i.e., sulfonylureas and exogenous insulin) could be related to higher cancer risk [29]. This evidence concerns the gene INS and cancer.